Literature DB >> 22170966

Long-term IL-1β exposure causes subpopulation-dependent alterations in rat dorsal root ganglion neuron excitability.

Patrick L Stemkowski1, Peter A Smith.   

Abstract

The effect of interleukin-1β (IL-1β) on the electrical properties of sensory neurons was assessed at levels and exposure times comparable to those found in animal models of neuropathic pain. Experiments involved whole cell current-clamp recordings from rat dorsal root ganglion (DRG) neurons in defined-medium, neuron-enriched cultures. Five- to six-day exposure to 100 pM IL-1β produced subpopulation-dependent effects on DRG neurons. These included an increase in the excitability of medium-diameter and small-diameter isolectin B(4) (IB(4))-positive neurons that was comparable to that found after peripheral nerve injury. By contrast, a reduction in excitability was observed in large-diameter neurons, while no effect was found in small-diameter IB(4)-negative neurons. Further characterization of changes in medium and small IB(4)-positive neurons revealed that some, but not all, effects of IL-1β were mediated through its receptor, IL-1RI. Although the acute actions of IL-1β on sensory neurons have been well studied and related to acute and/or inflammatory pain, the present study shows how sensory neurons respond to long-term cytokine exposure. Such effects are relevant to understanding processes that contribute to the onset of neuropathic pain.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22170966     DOI: 10.1152/jn.00587.2011

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  17 in total

Review 1.  Osteoarthritis joint pain: the cytokine connection.

Authors:  Rachel E Miller; Richard J Miller; Anne-Marie Malfait
Journal:  Cytokine       Date:  2014-07-24       Impact factor: 3.861

2.  Pannexin 1 channels mediate the release of ATP into the lumen of the rat urinary bladder.

Authors:  Jonathan M Beckel; Stephanie L Daugherty; Pradeep Tyagi; Amanda S Wolf-Johnston; Lori A Birder; Claire H Mitchell; William C de Groat
Journal:  J Physiol       Date:  2015-02-11       Impact factor: 5.182

Review 3.  Targeting cytokines for treatment of neuropathic pain.

Authors:  Alice L Hung; Michael Lim; Tina L Doshi
Journal:  Scand J Pain       Date:  2017-08-24

4.  Increased excitability of medium-sized dorsal root ganglion neurons by prolonged interleukin-1β exposure is K(+) channel dependent and reversible.

Authors:  Patrick L Stemkowski; Myung-Chul Noh; Yishen Chen; Peter A Smith
Journal:  J Physiol       Date:  2015-07-26       Impact factor: 5.182

5.  Balancing GRK2 and EPAC1 levels prevents and relieves chronic pain.

Authors:  Huijing Wang; Cobi J Heijnen; Cindy T J van Velthoven; Hanneke L D M Willemen; Yoshihiro Ishikawa; Xinna Zhang; Anil K Sood; Anne Vroon; Niels Eijkelkamp; Annemieke Kavelaars
Journal:  J Clin Invest       Date:  2013-11-15       Impact factor: 14.808

6.  Interleukin-1β increased the expression of protease-activated receptor 4 mRNA and protein in dorsal root ganglion neurons.

Authors:  Zhaojin Wang; Dan Chen; Rui Zhang; Shuhong An; Zaifeng Zhang; Qingyuan Ma
Journal:  Neurochem Res       Date:  2013-06-18       Impact factor: 3.996

7.  Condition-specific role of colonic inflammatory molecules in persistent functional colorectal hypersensitivity in the mouse.

Authors:  J-H La; G F Gebhart
Journal:  Neurogastroenterol Motil       Date:  2014-10-13       Impact factor: 3.598

Review 8.  Osteoarthritis pain mechanisms: basic studies in animal models.

Authors:  R-X Zhang; K Ren; R Dubner
Journal:  Osteoarthritis Cartilage       Date:  2013-09       Impact factor: 6.576

9.  Sigma-1 receptor expression in sensory neurons and the effect of painful peripheral nerve injury.

Authors:  Madhavi L Bangaru; Dorothee Weihrauch; Qing-Bo Tang; Vasiliki Zoga; Quinn Hogan; Hsiang-en Wu
Journal:  Mol Pain       Date:  2013-09-10       Impact factor: 3.395

10.  Immunotherapy targeting cytokines in neuropathic pain.

Authors:  Justin G Lees; Samuel S Duffy; Gila Moalem-Taylor
Journal:  Front Pharmacol       Date:  2013-11-22       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.